Skip to main content
VKTX logo

VKTX · Viking Therapeutics, Inc.

Track VKTX — free
$33.19 +0.25 (+0.76%) At close · Aug 14
Market Cap
$3.87B
Shares
116.65M

Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.

Filed Seller Shares
2026-07-29 BRIAN LIAN 148,517
2026-07-29 MARIANNA MANCINI 18,217
2026-07-29 GREG ZANTE 21,217
2026-01-05 BRIAN LIAN 233,409
2026-01-05 MARIANNA MANCINI 57,661
2026-01-05 GREG ZANTE 57,661
2026-01-02 MATTHEW W. FOEHR 16,000
2025-10-28 GREG ZANTE 6,185
2025-10-28 BRIAN LIAN 38,989
2025-10-28 MARIANNA MANCINI 6,185
2025-10-27 CHARLES A ROWLAND JR. 60,000
2025-07-03 GREG ZANTE 4,266
2025-07-03 BRIAN LIAN 26,889
2025-07-03 MARIANNA MANCINI 4,266
2025-01-06 BRIAN LIAN 194,490
2025-01-06 MARIANNA MANCINI 54,215
2025-01-06 GREG ZANTE 50,309
2024-11-08 LAWSON MACARTNEY 2,000
2024-10-28 GREG ZANTE 131,687
2024-10-25 SINGLETON J MATTHEW 16,000
2024-10-25 Rouan Sarah Kathryn 11,000
2024-09-20 SINGLETON J MATTHEW 10,300
2024-09-20 Lian Brian 216,130
2024-08-21 Lian Brian 1,000
2024-08-21 SINGLETON J MATTHEW 5,700
2024-08-19 Lian Brian 112,870
2024-08-19 SINGLETON J MATTHEW 16,000
2024-08-14 SINGLETON J MATTHEW 20,786
2024-07-30 GREG ZANTE 16,136
2024-07-30 MARIANNA MANCINI 18,026
2024-07-30 BRIAN LIAN 115,859
2024-05-03 ZANTE GREG 66,756
2024-05-01 Mancini Marianna 281,425
2024-02-09 Lian Brian 45,000
2024-02-08 Lian Brian 269,079
2024-02-08 Rouan Sarah Kathryn 25,000
2024-01-31 Lian Brian 85,000
2024-01-30 Lian Brian 35,000
2024-01-19 Rouan Sarah Kathryn 30,000
2024-01-04 ZANTE GREG 15,000
2023-05-16 Rowland Charles A Jr 40,000
2023-05-16 MACARTNEY LAWSON 16,000
2023-05-01 Lian Brian 45,000
2023-04-24 MACARTNEY LAWSON 16,000
2023-04-19 Lian Brian 35,000
2023-04-17 Lian Brian 155,000
2023-04-17 Lian Brian 79,336
2023-04-17 MACARTNEY LAWSON 20,785
2023-04-17 Mancini Marianna 12,500
2023-04-17 ZANTE GREG 7,500
Showing 1–50 of 50 filings
Key facts CIK 1607678 CUSIP 92686J106 13F (30d) 400 filings 394 filers Visit website Investor relations